Skip to content

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

Home
Pharma applications
Non-pharma applications
CD derivatives
Events
E-ducation

Tag: 5-féuorouracyl

January 29, 2026 Drug delivery / Pharma applications

Poly(β-cyclodextrin)-coated dysprosium-doped ZnS nanocarriers

This study provides a comprehensive analysis of the structures and properties of zinc sulfide (ZnS) and dysprosium-doped ZnS nanoparticles (NPs)

Continue reading

Search for:

Recent Posts

Events of American Cyclodextrin Consortium
Ultrafast-dissolving ocular microneedle patch with voriconazole-cyclodextrin complex
Nano-Enabled Toxicity of Pharmaceutical Excipients
Cyclodextrins Across the Eye-Care Spectrum
Biphasic dissolving microneedles with cyclodextrin inclusion complexes for enhanced delivery of poorly soluble drugs

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

LinkedIn
X
Facebook

Categories

Agriculture (27)
Analysis (66)
CD as API (347)
CD derivatives (410)
Cosmetics and toilettry (51)
Diagnosis (12)
Drug delivery (790)
E-ducation (63)
Environmental (134)
Events (234)
Food (221)
Gene delivery (20)
Household products (4)
Household products (1)
In Hungarian (4)
Life sciences (42)
Non-pharma applications (399)
Other industrial use (106)
Pharma applications (1,182)
Supramolecular systems (40)
Uncategorized (146)

Top Posts

Cyclarity Unveils First-Ever Clinical Data Demonstrating Excretion of Oxidized Cholesterol, at American Heart Association Vascular Discovery Scientific Sessions
How air fresheners work?
β-Cyclodextrin functionalized agarose-based hydrogels for multiple controlled drug delivery of ibuprofen
CD-based supramolecular polymers based on host–guest interactions for cancer therapy
Events of American Cyclodextrin Consortium
Use of cyclodextrins in diseases and disorders involving phospholipid dysregulation
Using cyclodextrin is not rocket science...except for NASA researchers.
21st International Cyclodextrin Symposium - Deadline for abstract submission extended to February 14, 2024
Oculis aces the Phase 2 clinical trial for OCS-01 treating DME
Hepta-differentiated beta-cyclodextrin was obtained through a programmed synthesis

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Email Address

Join 4,472 other subscribers

Loading Comments...

Write a Comment...

Email (Required)

Name (Required)

Website